Cefdinir Dosage for a 2-Year-Old Child (12 kg)
For a 2-year-old child weighing 12 kg, cefdinir should be dosed at 7 mg/kg every 12 hours OR 14 mg/kg once daily, which translates to approximately 84 mg twice daily (2.5 mL of the 250 mg/5 mL suspension twice daily) OR 168 mg once daily (5 mL of the 250 mg/5 mL suspension once daily). 1
Specific Dosing by Indication
The total daily dose is 14 mg/kg (up to 600 mg maximum per day), which can be administered as:
For Acute Otitis Media or Pharyngitis/Tonsillitis:
- 7 mg/kg every 12 hours for 5-10 days, OR
- 14 mg/kg once daily for 10 days 1
For your 12 kg child:
- 84 mg (2.5 mL of 250 mg/5 mL suspension) twice daily, OR
- 168 mg (5 mL of 250 mg/5 mL suspension) once daily
For Acute Maxillary Sinusitis:
- Same dosing as above but duration is 10 days 1
For Uncomplicated Skin/Soft Tissue Infections:
- 7 mg/kg every 12 hours for 10 days ONLY (once-daily dosing has not been studied for skin infections) 1
Important Clinical Context
Cefdinir is listed as an alternative agent for β-lactamase-producing Haemophilus influenzae in pediatric community-acquired pneumonia guidelines 2, 3, but it is not a first-line agent. The guidelines prioritize amoxicillin or amoxicillin-clavulanate for most pediatric respiratory infections.
Key Caveats:
Food Effect: Cefdinir bioavailability is reduced by 44% (Cmax) and 33% (AUC) when given with high-fat meals in suspension form 1. However, the FDA label states it may be administered without regard to meals since pediatric efficacy studies were conducted without controlling for food intake 1.
Once-Daily vs Twice-Daily: Once-daily dosing is as effective as twice-daily dosing for otitis media, sinusitis, and pharyngitis, but has not been validated for skin infections 1.
Renal Adjustment: If creatinine clearance is <30 mL/min/1.73 m², reduce dose to 7 mg/kg once daily 1.
Storage: After reconstitution, suspension is stable for 10 days at room temperature; shake well before each use 1.
Appropriateness Considerations
Recent evidence suggests cefdinir is frequently inappropriately prescribed—57% of pediatric cefdinir prescriptions were deemed potentially inappropriate in a large health system analysis 4. Cefdinir should generally be reserved for:
- Documented β-lactamase-producing organisms
- True penicillin allergy (though second/third-generation cephalosporins carry minimal cross-reactivity risk)
- Treatment failure with first-line agents
For urinary tract infections specifically, cefdinir has shown significantly higher treatment failure rates (23.4% vs 12.5%) compared to cephalexin 5, and should be avoided for this indication despite its FDA approval.